Recruiting NCT06820606

Comparing Rezum and Urolift

Prostate CancerN/A

This is a randomized controlled trial using a non-inferiority design with the subjects randomized 1:1 to either water vapour thermal treatment (REZUM) arm or prostatic urethral lift (UroLift) arm.

Conditions: Prostate Cancer

Eligibility Criteria

Inclusion Criteria

  • Male ≥ 50 years Symptomatic BPH International prostate symptom score (IPSS) ≥13 Prostate volume 30-80ml

Exclusion Criteria

  • History or high suspicion of prostate cancer
  • Current urinary tract infection
  • Refractory urinary retention or post-void residual (PVR) ≥250 mL
  • Intravesical prostatic protrusion (IPP)\>10mm
  • Prior prostate surgery
  • Known or suspected allergy to nickel, titanium, or polyester/polypropylene
  • Urethral stricture, meatal stenosis, bladder neck contracture
  • Neurogenic bladder and/or sphincter abnormalities

Eligibility criteria are kept as the original English records from ClinicalTrials.gov; actual eligibility is determined by the research team's formal assessment and the informed consent form. Source: ClinicalTrials.gov, updated automatically every two weeks. Last synced: 2026年10月8日.